Dutch company Mint Solutions has raised €4.4 million in a Series A round led by Life Sciences Partners (LSP) and co-led by Seventure Partners with participation from existing investors. As part of this investment the company will relocate headquarters to the Netherlands.
Mint’s flagship MedEye product aims to prevent medication errors in hospitals and improve efficiency. Its hardware and software integrates into existing hospital infrastructure and helps hospitals and nurses ensure that all medications – from tablets to syringes – are correctly administered to the right patient at the right time. MedEye has been deployed in the Netherlands with further roll-outs planned there, the UK and Germany.
The company participated in the Startupbootcamp HighTechXL, an accelerator program in Eindhoven, The Netherlands. “We have also decided to set up our headquarters here to take advantage of the positive response we have been seeing over the last 12 months”, said Gauti Reynisson, CEO of Mint Solutions in a statement.